KPIs & Operating Metrics(New)

Balance Sheet

Cash Flow Statement

Acquisitions Amortization of Deferred Charges Amortization of Deferred Charges Amortizatization of Intangibles Amortizatization of Intangibles Asset Writedowns and Impairment Asset Writedowns and Impairment Capital Expenditures Capital Expenditures Cash from Financing Activities Cash from Financing Activities Cash from Investing Activities Cash from Investing Activities Cash from Operations Cash from Operations Change in Account Payables Change in Account Payables Change in Accured Expenses Change in Accured Expenses Change in Acquisitions & Divestments Change in Acquisitions & Divestments Change in Cash Change in Inventory Change in Inventory Change in Receivables Change in Receivables Change in Taxes Change in Taxes Deferred Taxes Depreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and Depletion Depreciation and Depletion Dividends Paid - Common Dividends Paid - Common Exchange Rate Effect Exchange Rate Effect Free Cash Flow Free Cash Flow Gains from Investment Securities Gains from Investment Securities Gains from Sales and Divestitures Gains from Sales and Divestitures Long-Term Debt Issuances Long-Term Debt Repayments Net Cash Flow Net Cash Flow Net Income Non-cash Items Non-cash Items Other Working Capital Changes Other Working Capital Changes Other financing activities Other financing activities Preferred Shares Repurchased Sales of Property, Plant and Equipment Sales of Property, Plant and Equipment Share-based Compensation Share-based Compensation Shares Issued Short-Term Debt issuances Short-Term Debt repayments

Daily Values

Growth Metrics

Biolife Solutions (BLFS) Free Cash Flow (2016 - 2025)

Biolife Solutions (BLFS) has disclosed Free Cash Flow for 16 consecutive years, with $658000.0 as the latest value for Q4 2025.

Quarterly Free Cash Flow fell 59.76% to $658000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $10.6 million through Dec 2025, up 27.79% year-over-year, with the annual reading at $10.6 million for FY2025, 27.79% up from the prior year.
Free Cash Flow for Q4 2025 was $658000.0 at Biolife Solutions, down from $974000.0 in the prior quarter.
The five-year high for Free Cash Flow was $9.0 million in Q4 2022, with the low at -$9.4 million in Q1 2022.
Average Free Cash Flow over 5 years is -$1.1 million, with a median of -$34500.0 recorded in 2022.
The sharpest move saw Free Cash Flow crashed 11984.13% in 2023, then skyrocketed 27350.0% in 2024.
Over 5 years, Free Cash Flow stood at -$2.3 million in 2021, then skyrocketed by 486.32% to $9.0 million in 2022, then crashed by 100.07% to -$6000.0 in 2023, then surged by 27350.0% to $1.6 million in 2024, then tumbled by 59.76% to $658000.0 in 2025.
According to Business Quant data, Free Cash Flow over the past three periods came in at $658000.0, $974000.0, and $7.8 million for Q4 2025, Q3 2025, and Q2 2025 respectively.